In this model, CER-1236 not only mobilize proinflammatory (IFN-γ, TNF-α, chemokines) and cytotoxic functions but also process tumor-associated antigens to generate tumor antigen-specific T cells, and therefore overcome antigen presentation defects in the tumor microenvironment. The gene discussed is IFNG; the disease is neoplasm.